Temporarily Closed. New orders are paused while we resolve an unforeseen operational issue. Existing orders will still be fulfilled.
PolarisResearch
0

TB-500

Accelerating

TB-500 appears in 1,177 indexed publications going back to 1982, including 33 in the past twelve months. 15 registered trials appear on ClinicalTrials.gov.

1,177
Indexed publications
33
Past 12 months, against 23 the year before
15
Registered clinical trials
1,614
Monthly readers on Wikipedia, up 0%

On This Figure
Most of this literature studies thymosin beta 4, the endogenous protein TB-500 is derived from, rather than the TB-500 fragment itself.

Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
201545
201636
201738
201843
201927
202022
202142
202224
202334
202413
202526
202627
Public Attention

Who is looking it up

Monthly readers of the TB-500 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-092026-08
Clinical Trials

The registered pipeline

Early Phase 1
0
Phase 1
2
Phase 2
10
Phase 3
5
Phase 4
0

Phase distribution across the most recently updated registered trials.

References

Most recent work

The newest indexed records mentioning TB-500, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

  1. 2026-07-10·Experimental eye research

    Understanding the effects of ciprofloxacin on corneal epithelial cells: a study using electric cell-substrate impedance sensing (ECIS) technology

    Banga L, Shawky M, Ebrahim F et al.

  2. 2026-08-24·Current pain and headache reports

    Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management

    Luansritisakul C, Chiang MC, Burns SL et al.

  3. 2026-08-17·Molecular biomedicine

    Recombinant human Thymosin β4 ameliorates experimental colitis and intestinal fibrosis through suppression of mineralocorticoid receptor signaling

    Zhao TR, Hu EB, Wang MW et al.

  4. 2026-08-11·The American journal of sports medicine

    Peptide Supplements and Their Therapeutic Applications in Sports Medicine

    Tewari K, Liu TP, Im C et al.

  5. 2026-08-01·Clinical science (London, England : 1979)

    Thymosin β4 alleviates sepsis-associated acute kidney injury by suppressing MAPK signaling pathway

    Ouyang X, Long Z, Xu X et al.

  6. 2026-04-12·Sports medicine (Auckland, N.Z.)

    Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance

    Mendias CL, Awan TM. et al.

  7. 2026-07-23·Joint diseases and related surgery

    Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study

    Biçer O, Adanir O, Güleryüz Y et al.

  8. 2026-07-01·Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

    [Thymosin β4 inhibits pyroptosis in BV2 microglial cells: a mechanistic study <i>in vitro</i>]

    Li YX, Chen CL, Zheng SD et al.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-09-13.